The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma

Last updated: January 24, 2025
Sponsor: University of Florida
Overall Status: Active - Recruiting

Phase

N/A

Condition

Anemia

Hyponatremia

Treatment

Data and tissue collection

Clinical Study ID

NCT06606119
IRB202400903
1R35GM152216-01
  • Ages 18-100
  • All Genders

Study Summary

Traumatic injury followed by critical illness provokes pathophysiologic changes in the bone marrow and the gut that contribute to persistent anemia and changes in the microbiome which significantly impact long-term recovery. This project will define the interactions between the stress, chronic inflammation, bone marrow dysfunction, and an altered microbiome which will provide a strong foundation for future clinical interventions to help improve outcomes following severe trauma.

Eligibility Criteria

Inclusion

Severe Trauma Cohort

Inclusion Criteria:

  1. All adults (age ≥18).

  2. Blunt trauma with an injury severity score > 15 and a long bone or pelvic fracturerequiring open reduction internal fixation or intramedullary fixation

  3. Blunt trauma patients with shock, defined by either a systolic BP (SBP) <90 mm Hg orbase deficit (BD) ≥5 meq or lactate ≥ 2 mmol/L or active red blood cell or wholeblood transfusion within 6h or arrival

Exclusion

Exclusion Criteria:

  1. Patients not expected to survive greater than 48 hours

  2. Prisoners

  3. Pregnancy

  4. Previous bone marrow transplantation

  5. Patients receiving chronic corticosteroids or immunosuppression therapies

  6. Patients with End Stage Renal Disease

  7. Patients with any pre-existing hematological disease

  8. Surgery for repair of injury is greater than seven days after admission to thehospital for trauma

  9. Burn injury greater than 20% TBSA

Elective Hip Cohort

Inclusion Criteria

  1. All adults (age ≥55).

  2. Patient undergoing elective hip repair for non-infectious reasons.

  3. Ability to obtain Informed Consent prior to operation.

Exclusion Criteria

  1. Patients not expected to survive greater than 48 hours

  2. Prisoners

  3. Pregnancy

  4. Previous bone marrow transplantation

  5. Patients receiving chronic corticosteroids or immunosuppression therapies

  6. Patients with End Stage Renal Disease

  7. Patients with any pre-existing hematological disease

Study Design

Total Participants: 275
Treatment Group(s): 1
Primary Treatment: Data and tissue collection
Phase:
Study Start date:
January 24, 2025
Estimated Completion Date:
October 01, 2028

Study Description

Trauma remains the leading cause of death among people younger than 46 years of age and is the leading cause of years of potential life lost among those younger than 65. With more lives saved, trauma morbidity has increased, which has consequently revealed a lack of understanding of the impact of trauma survivorship on the patients' quality of life and long-term recovery. Severe injury when followed by chronic critical illness leads to persistent anemia, and the use of blood transfusions is associated with a linear increase in infectious complications. These conditions are due to prolonged bone marrow dysfunction associated with an exaggerated catecholamine response, chronic stress, and systemic inflammation. Our laboratory has conducted human research to establish that there are unique bone marrow transcriptomic differences related to inflammation, the innate immune response, and known inhibitors of erythropoiesis following trauma. The laboratory has also discovered that chronic stress after trauma contributes to persistent anemia with impaired iron and erythropoietin function along with the prolonged loss of hematopoietic stem progenitor cells (HSPC) from the bone marrow. Chronic stress after trauma also induces an altered microbiome with decreased alpha and beta diversity and changes in microbial composition leading to a persistent 'pathobiome'. All of these factors influence outcomes. We hypothesize that there is a unifying interaction between stress, inflammation, and the microbiome and this has an overall role in the regulation of HSPC and erythroid progenitor cell fate and function following trauma and critical illness. Therefore, the overarching goal for this study is to build upon this foundation and expand our understanding of HSPC fate and function following trauma, including examining interventions aimed at reducing stress/inflammation and restoring the microbiome, thus, improving long-term outcomes.

Connect with a study center

  • UF Academic Research Building

    Gainesville, Florida 32610
    United States

    Active - Recruiting

  • UF Health at Shands Hospital

    Gainesville, Florida 32610
    United States

    Active - Recruiting

  • UF Laboratory of Inflammation Biology and Surgical Science and Shands Hospital at UF

    Gainesville, Florida 32610
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.